Emmprin in epithelioid sarcoma: Expression in tumor cell membrane and stimulation of MMP-2 production in tumor-associated fibroblasts
Kaori Koga
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Department of Dermatology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorCorresponding Author
Kazuki Nabeshima
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Fax: +81-92-861-7300.
Department of Pathology, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, JapanSearch for more papers by this authorMikiko Aoki
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorTakehito Kawakami
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorMakoto Hamasaki
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorBryan P. Toole
Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston, SC
Search for more papers by this authorJuichiro Nakayama
Department of Dermatology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorHiroshi Iwasaki
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorKaori Koga
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Department of Dermatology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorCorresponding Author
Kazuki Nabeshima
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Fax: +81-92-861-7300.
Department of Pathology, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, JapanSearch for more papers by this authorMikiko Aoki
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorTakehito Kawakami
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorMakoto Hamasaki
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorBryan P. Toole
Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston, SC
Search for more papers by this authorJuichiro Nakayama
Department of Dermatology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorHiroshi Iwasaki
Department of Pathology, Fukuoka University School of medicine, Fukuoka, Japan
Search for more papers by this authorAbstract
Emmprin is a transmembrane glycoprotein on tumor cells that stimulates peritumoral fibroblasts to produce matrix metalloproteinases (MMPs). Emmprin and the induced MMPs play a crucial role in tumor progression, invasion and metastasis of human carcinomas (epithelial malignancies). However, only a few reports have addressed its role in soft tissue sarcomas. This study investigated the expression and role of emmprin in epithelioid sarcoma (ES). Immunoblot studies of 2 ES cell lines showed that they express emmprin, and co-culture of these ES cells with dermal fibroblasts resulted in upregulation of gelatinase A (MMP-2) in fibroblasts, as shown by zymography, immunoblotting and enzyme immunoassay. This stimulation was inhibited by an activity-blocking peptide against emmprin and by antiemmprin antibody. In addition, in vivo, immunohistochemical analysis of 5 ES patient cases demonstrated diffuse emmprin expression in ES cells and MMP-2 expression in both ES cells and peritumoral fibroblasts. The histopathological findings that peritumoral fibroblasts that were not in direct contact with emmprin-expressing ES cells exhibit upregulated MMP-2 prompted us to look for a soluble form of emmprin. Soluble full-length emmprin released from ES cells was detected in conditioned medium and shown to stimulate MMP-2 production by fibroblasts. In conclusion, emmprin is expressed in ES in both membrane and soluble forms and stimulates MMP-2 production via interactions with fibroblasts, which could play a role in ES cell stromal invasion and vascular involvement. © 2006 Wiley-Liss, Inc.
References
- 1 Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327–36.
- 2 Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348: 699–704.
- 3 Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L, Stamp GW. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992; 141: 389–96.
- 4 Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon Pa, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas. Proc Natl Acad Sci USA 1995; 92: 2730–4.
- 5 Biswas C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun 1982; 109: 1026–34.
- 6 Ellis SM, Nabeshima K, Biswas C. Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res 1989; 49: 3385–91.
- 7 Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55: 434–9.
- 8 Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M, Wakisaka S. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000; 157: 177–84.
- 9 Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 520–8.
- 10 Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 2004; 92: 47–56.
- 11 Nabeshima K, Lane WS, Biswas C. Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys 1991; 285: 90–6.
- 12 Guo H, Zucker S, Gordon MK, Toole BP, Biswas C. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 1997; 272: 24–7.
- 13 Taylor PM, Woodfield RJ, Hodgkin MN, Pettitt TR, Martin A, Kerr DJ, Wakelam MJ. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene 2002; 21: 5765–72.
- 14 Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 2004; 23: 956–63.
- 15 Tang Y, Kesavan P, Nakada MT, Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2004; 2: 73–80.
- 16 Muraoka K, Nabeshima K, Murayama T, Biswas C, Koono M. Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers. Int J Cancer 1993; 55: 19–26.
- 17 Polette M, Gilles C, Marchand V, Lorenzato M, Toole B, Tournier JM, Zucker S, Birembaut P. Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 1997; 45: 703–9.
- 18
Bordador LC,
Li X,
Toole B,
Chen B,
Regezi J,
Zardi L,
Hu Y,
Ramos DM.
Expression of emmprin by oral squamous cell carcinoma.
Int J Cancer
2000;
85:
347–52.
10.1002/(SICI)1097-0215(20000201)85:3<347::AID-IJC9>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 19 Ishibashi Y, Matsumoto T, Niwa M, Suzuki Y, Omura N, Hanyu N, Nakada K, Yanaga K, Yamada K, Ohkawa K, Kawakami M, Urashima M. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 2004; 101: 1994–2000.
- 20 Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M, Wakisaka S. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 2000; 88: 21–7.
- 21 Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis 2003; 20: 161–9.
- 22
Enzinger FM.
Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma.
Cancer
1970;
26:
1029–41.
10.1002/1097-0142(197011)26:5<1029::AID-CNCR2820260510>3.0.CO;2-R CAS PubMed Web of Science® Google Scholar
- 23 Chase DR, Enzinger FM. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol 1985; 9: 241–63.
- 24 Halling AC, Wollan PC, Pritchard DJ, Vlasak R, Nascimento AG. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc 1996; 71: 636–42.
- 25
Engers R,
Gerharz CD,
Donner A,
Mrzyk S,
Krause-Paulus R,
Petek O,
Gabbert HE.
In vitro invasiveness of human epithelioid-sarcoma cell lines: association with cell motility and inverse correlation with the expression of tissue inhibitor of metalloproteinases.
Int J Cancer
1999;
80:
406–12.
10.1002/(SICI)1097-0215(19990129)80:3<406::AID-IJC12>3.0.CO;2-L CAS PubMed Web of Science® Google Scholar
- 26 Guillou L, Kaneko Y. Epithelioid sarcoma. In: F Mertens, ed. WHO classification. Tumors of soft tissue and bone. Lyon: IARC Press, 2002. 205–7.
- 27 Nishio J, Iwasaki H, Nabeshima K, Ishiguro M, Naumann S, Isayama T, Naito M, Kaneko Y, Kikuchi M, Bridge JA. Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization. Int J Oncol 2005; 27: 361–9.
- 28 Iwasaki H, Ohjimi Y, Ishiguro M, Isayama T, Kaneko Y, Yoh S, Emoto G, Kikuchi M. Epithelioid sarcoma with an 18q aberration. Cancer Genet Cytogenet 1996; 91: 46–52.
- 29 Nabeshima K, Suzumiya J, Nagano M, Ohshima K, Toole BP, Tamura K, Iwasaki H, Kikuchi M. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol 2004; 202: 341–51.
- 30 Horstkorte R, Schachner M, Magyar JP, Vorherr T, Schmitz B. The fourth immunoglobulin-like domain of NCAM contains a carbohydrate recognition domain for oligomannosidic glycans implicated in association with L1 and neurite outgrowth. J Cell Biol 1993; 121: 1409–21.
- 31 Heller M, von der Ohe M, Kleene R, Mohajeri MH, Schachner M. The immunoglobulin-superfamily molecule basigin is a binding protein for oligomannosidic carbohydrates: an anti-idiotypic approach. J Neurochem 2003; 84: 557–65.
- 32 Overall CM, Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J Biol Chem 1990; 265: 21141–51.
- 33 Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005; 65: 3193–9.
- 34 Marieb EA, Zoltan-Jones A, Li R, Misra S, Ghatak S, Cao J, Zucker S, Toole BP. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res 2004; 64: 1229–32.
- 35 Misra S, Ghatak S, Zoltan-Jones A, Toole BP. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 2003; 278: 25285–8.
- 36 Reimers N, Zafrakas K, Assmann V, Egen C, Riethdorf L, Riethdorf S, Berger J, Ebel S, Janicke F, Sauter G, Pantel K. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clin Cancer Res 2004; 10: 3422–8.
- 37 Benassi MS, Gamberi G, Magagnoli G, Molendini L, Ragazzini P, Merli M, Chiesa F, Balladelli A, Manfrini M, Bertoni F, Mercuri M, Picci P. Metalloproteinase expression and prognosis in soft tissue sarcomas. Ann Oncol 2001; 12: 75–80.
- 38 Saito T, Oda Y, Sakamoto A, Tamiya S, Iwamoto Y, Tsuneyoshi M. Matrix metalloproteinase-2 expression correlates with morphological and immunohistochemical epithelial characteristics in synovial sarcoma. Histopathology 2002; 40: 279–85.
- 39 Sugita H, Osaka S, Toriyama M, Osaka E, Yoshida Y, Ryu J, Sano M, Sugitani M, Nemoto N. Correlation between the histological grade of chondrosarcoma and the expression of MMPs, ADAMTSs and TIMPs. Anticancer Res 2004; 24: 4079–84.
- 40 Roebuck MM, Helliwell TR, Chaudhry IH, Kalogrianitis S, Carter S, Kemp GJ, Ritchie DA, Jane MJ, Frostick SP. Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities. Am J Clin Pathol 2005; 123: 405–14.
- 41 Menashi S, Serova M, Ma L, Vignot S, Mourah S, Calvo F. Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 2003; 63: 7575–80.
- 42 Shi Y, Simmons MN, Seki T, Oh SP, Sugrue SP. Change in gene expression subsequent to induction of Pnn/DRS/memA: increase in p21(cip1/waf1). Oncogene 2001; 20: 4007–18.
- 43 Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg 2000; 24: 334–40.
Citing Literature
